Kerin Adelson, MD
Associate Professor AdjunctCards
Appointments
Contact Info
Yale Cancer Center
333 Cedar Street, PO Box 208028
New Haven, CT 06520-8028
United States
About
Titles
Associate Professor Adjunct
Biography
Dr. Adelson is an Adjunct Associate Professor and was previously Chief Quality Officer for Yale Cancer Center and Smilow Cancer Hospital. Dr. Adelson graduated from Yale University School of Medicine, completed residency at Mount Sinai Medical Center and Fellowship in oncology at Columbia Presbyterian. In her Quality role, Dr. Adelson focused on improving care coordination for all patients treated in the Smilow network, aligning care with national quality metrics, and developing models to enhance patient involvement in decisions about their cancer-care. Dr. Adelson sits on several national committees including the Southwest Oncology group Cancer Delivery Committee, the National Cancer Care Network Policy Committee and the American Society of Clinical Oncology Health Information Technology Committee.
Appointments
Medical Oncology and Hematology
Associate Professor AdjunctPrimary
Other Departments & Organizations
- Internal Medicine
- Medical Oncology
- Medical Oncology and Hematology
- Pusztai Lab
- Subset Medical Oncology Faculty
- Yale Cancer Center
Education & Training
- Fellowship
- Columbia University College of Physicians and Surgeons (2007)
- Residency
- Mount Sinai School of Medicine (2003)
- Internship
- Mount Sinai School of Medicine (2001)
- MD
- Yale School of Medicine (2000)
Research
Overview
Dr. Adelson is actively involved in breast cancer clinical research and serves as an investigator on multiple clinical trials.
Medical Research Interests
ORCID
0009-0004-4507-4502
Research at a Glance
Yale Co-Authors
Publications Timeline
Cary Gross, MD
Maureen Canavan, PhD, MPH
Lajos Pusztai, MD, DPhil
Anne Chiang, MD, PhD
Andrea Silber, MD
Roy S. Herbst, MD, PhD
Publications
2025
Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences.
Huey R, Pritchett J, Vokinger K, Swenson W, Haddad T, Adelson K. Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences. American Society Of Clinical Oncology Educational Book 2025, 45: e473822. PMID: 40526882, DOI: 10.1200/edbk-25-473822.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsCancer care deliveryCancer care costsSite of careRemote patient monitoringCare deliveryCancer careCost-containment strategiesUnited StatesTelehealth servicesCare costsVulnerable populationsPayment barriersPayment parityFacility feesCareStandard of careIncremental costHospitalHealthReimbursementPolicy changesPatient monitoringCancer treatmentUnintended consequencesComparator countriesOP-35: Does a tool designed to measure potentially preventable chemotherapy toxicities do so effectively?
Huey R, Zafar A, Le P, Sanchez N, Patlovich K, Olivieri N, Singhi E, Rivera J, Roux R, Adelson K. OP-35: Does a tool designed to measure potentially preventable chemotherapy toxicities do so effectively? Journal Of Clinical Oncology 2025, 43: 1538-1538. DOI: 10.1200/jco.2025.43.16_suppl.1538.Peer-Reviewed Original ResearchConceptsQualifying diagnosisRates of emergency department visitsSecondary diagnosisOutpatient chemotherapy treatmentQuality of careEmergency department visitsCenters for MedicareChemotherapy treatmentRetrospective review of patientsMeasures of qualityDepartment visitsUniversity of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterPreventive visitsChemotherapy-related complicationsReview of patientsAnti-cancer therapyComplication of chemotherapy treatmentDiagnosis groupsCancer CenterChemotherapy toxicityPatient 1Retrospective reviewVisitsNational Quality FoundationAdvance care planning documentation prior to end-of-life systemic therapy: A single institution retrospective review.
Xiang J, Wiese B, Patlovich K, Taylor J, Adelson K, Ratan R. Advance care planning documentation prior to end-of-life systemic therapy: A single institution retrospective review. Journal Of Clinical Oncology 2025, 43 DOI: 10.1200/jco.2025.43.16_suppl.e24031.Peer-Reviewed Original ResearchConceptsSystemic anticancer therapyMonths of lifeTargeted therapyDose of treatmentAdvance care planning notesFinal treatmentAdvance care planningEnd-of-lifeHigher risk of mortalityDocumented discussionAssociated with decreased quality of lifeRisk of mortalityAssociated with decreased qualityMetastatic diseaseHigh healthcare useInpatient settingSolid tumorsRetrospective studyMD AndersonCellular therapyMedical oncologistsAnticancer therapyImmunotherapyTherapyPatientsData Events Are Safety Events: High-Reliability Organization Approach to Improving Data Quality and Safety
Merriman K, Yu E, Hawkins-Daarud A, Adelson K, Shaw K, Shoenthal D, Patel J, Baganz J, Futreal A, Jaffray D, Rivera J, Chung C. Data Events Are Safety Events: High-Reliability Organization Approach to Improving Data Quality and Safety. JCO Clinical Cancer Informatics 2025, 9: e2400273. PMID: 40305760, PMCID: PMC12058365, DOI: 10.1200/cci-24-00273.Peer-Reviewed Original ResearchThe association between clinical trial participation, drug costs, and performance in the Oncology Care Model
Canavan M, Westvold S, Csik V, Franks J, Rocque G, Gross C, Adelson K. The association between clinical trial participation, drug costs, and performance in the Oncology Care Model. Journal Of The National Cancer Institute 2025, djaf008. PMID: 39842859, DOI: 10.1093/jnci/djaf008.Peer-Reviewed Original ResearchConceptsOncology Care ModelCare modelValue-based payment programsMedicare alternative payment modelsAlternative payment modelsRandom-effects meta-analysisImpact of clinical trialsClinical trial participationCT episodesEffects meta-analysisAcademic oncology practicesImprove careClinical trialsPatient complexityPayment modelsPayment programsMedicare costsTrial participantsOncology practiceCancer CenterMeta-analysisMedicareDrug costsParticipantsOncology
2024
Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis.
Adelson K, Canavan M, Niu J, Zhao H, Nortje N, Xiang J, Giordano S, Cheng L. Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis. Journal Of Clinical Oncology 2024, 20: 276-276. DOI: 10.1200/op.2024.20.10_suppl.276.Peer-Reviewed Original ResearchCitationsConceptsEnd-of-lifeSystemic anticancer therapyDay of deathIntensive care unit useIntensive care unitHealthcare utilizationEmergency departmentCombined chemo-immunotherapyEnd-of-life chemotherapy useAssociated with healthcare utilizationImmunotherapy useChemo-immunotherapyIncreased healthcare useEnd of lifeAdverse quality of lifeAssociated with higher EDCare unitQuality of lifeSystemic anti-cancer treatmentHospice useDay hospiceHospice enrollmentSEER-Medicare databaseUse of chemotherapyHealthcare useA Qualitative Study on the Impact and Feasibility of a Simulation-Based Program for Shared Decision-Making in Non–Small Cell Lung Cancer Care
Hakim H, Alexander C, Rudell E, Ingram M, Agrawal T, Peterson P, Davies M, Adelson K, Oliver B. A Qualitative Study on the Impact and Feasibility of a Simulation-Based Program for Shared Decision-Making in Non–Small Cell Lung Cancer Care. The Permanente Journal 2024, 28: 212-222. PMID: 39269215, PMCID: PMC11404665, DOI: 10.7812/tpp/23.152.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsShared decision-makingOncology cliniciansSDM principlesPerceptions of shared decision-makingImprove health care outcomesPatient-centred care modelComprehensive cancer care centerLeadership buy-inPatient-centered careHealth care outcomesLung cancer careParticipants perceived benefitsHealth care environmentTeam member rolesNon-small cell lung cancer careThematic analysis of interview dataCancer care centerSimulation-based programAnalysis of interview dataCare modelCare outcomesCancer carePatient-centeredPatient experienceCare environmentBuilding Frontline Capability for Shared Decision-Making (SDM) in a Major Academic Oncology Center Caring for People With Non–Small Cell Lung Cancer: Performance Outcomes of a SDM Simulation Training Program
Alexander C, Hakim H, Rudell E, Ingram M, Agrawal T, Peterson P, Davies M, Adelson K, Oliver B. Building Frontline Capability for Shared Decision-Making (SDM) in a Major Academic Oncology Center Caring for People With Non–Small Cell Lung Cancer: Performance Outcomes of a SDM Simulation Training Program. The Permanente Journal 2024, 28: 200-211. PMID: 39269220, PMCID: PMC11404653, DOI: 10.7812/tpp/23.160.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsShared decision-makingPractice settingsImplementation of shared decision-makingSDM trainingTraining programSimulation training programMultidisciplinary cliniciansCentered carePatient goalsPost-trainingClinician experienceFocus groupsClinical careSelf-efficacyParticipants' understandingClinician awarenessPostinterventionPilot studyActive participationParticipantsProgram designCareCliniciansBody of evidenceGrowing body of evidenceSystemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors
Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors. JAMA Oncology 2024, 10: 887-895. PMID: 38753341, PMCID: PMC11099840, DOI: 10.1001/jamaoncol.2024.1129.Peer-Reviewed Original ResearchCitationsAltmetricConceptsNational Quality ForumQuintile 5Quintile 1Improve end-of-life careEnd-of-life careCohort studyNationwide population-based cohort studyPopulation-based cohort studyEnd of lifeElectronic health record databaseHealth care practicesColorectal cancerPopulation of patientsCox proportional hazards modelsAmerican Society of Clinical OncologyQuality ForumCare practicesOverall survivalPayment incentivesProportional hazards modelHighest quintileMultivariate Cox proportional hazards modelQuintileFlatiron HealthHazard ratioPrognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma
Shimer S, Allen O, Yang C, Canavan M, Westvold S, Kim N, Morillo J, Parker T, Wallace N, Smith C, Adelson K. Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma. Journal Of Palliative Medicine 2024, 27: 879-887. PMID: 38990245, DOI: 10.1089/jpm.2023.0530.Peer-Reviewed Original ResearchCitationsAltmetricConceptsGoals of carePrognostic awarenessQuality of lifeIllness understandingPrognostic understandingMultiple myelomaHematologic malignanciesAcute leukemiaFaith-based responseInformed treatment choicesChi-square testCohort of patientsLikelihood ratio chi-square testMount Sinai HospitalTreatment goalsMM cohortSinai HospitalCarePatient populationTreatment choiceHospitalized patientsHematologistsAssess discordanceLeukemiaPatients
News & Links
News
- June 07, 2024
Yale Cancer Center Researchers and Trainees Present at ASCO
- March 11, 2024
Oncology Hospitalists Improve Hospice Transitions for Patients with Advanced Cancers
- July 03, 2023Source: AJMC
Poster Talks Explore How Policy, Payer Incentives Affect Cancer Care, Outcomes
- March 08, 2023
Involving Hospitalists in Inpatient Cancer Care Reduces Patient Stays, Oncologist Stress
Get In Touch
Contacts
Yale Cancer Center
333 Cedar Street, PO Box 208028
New Haven, CT 06520-8028
United States